アリゾナ州における膀胱癌の臨床試験
アリゾナ州内の拠点で、膀胱癌に関する20件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Banner University Medical Center - Tucson, Tucson
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06770582Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mayo Clinic Hospital in Arizona, Phoenix
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Phoenix, Goodyear
- Mayo Clinic Arizona, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
被験者募集中第1/2相
18歳〜99歳 · 全性別 · 2026/09/22更新 · NCT06814496ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Mayo Clinic, Phoenix
- East Valley Urology Center of Arizona, Queen Creek
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- East Valley Urology Center of Arizona, Queen Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/21更新 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Arizona - Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Mayo Clinic, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Local Institution - 0167, Gilbert
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/29更新 · NCT07106762A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Banner Gateway Medical Center, Gilbert
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- Mayo Clinic, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。